Literature DB >> 15991283

Activation of transcription factors NF-kappaB and AP-1 and their relations with apoptosis associated-proteins in hepatocellular carcinoma.

Lin-Lang Guo1, Sha Xiao, Ying Guo.   

Abstract

AIM: To study the distribution pattern of transcription factors NF-kappaB and AP-1 and their relations with the expression of apoptosis associated-proteins Fas/FasL and ICH-1L/S in human hepatocellular carcinoma (HCC).
METHODS: We performed in situ hybridization and immunohistochemical techniques for NF-kappaB, AP-1, Fas/FasL and ICH-1 in 40 cases of human HCC along with corresponding nontumoral tissues and 7 cases of normal liver tissues.
RESULTS: Twenty-two (55%) and 25 (62.5%) of 40 cases for NF-kappaB and AP-1 were presented for nuclear or both nuclear and cytoplastic staining respectively, while less cases were presented for only cytoplastic staining for NF-kappaB (18%) and AP-1 (10%) in adjacent nontumoral tissues and negative staining in normal liver tissues. There was no statistically significant difference of NF-kappaB or AP-1 activation between well differentiated tumors and poorly differentiated tumors (P>0.05). NF-kappaB activity is positively corresponded to AP-1 activation. The expression of ICH-1L/S was associated with the activation of NF-kappaB and AP-1 (P<0.05), but no significant relationship was found between Fas/FasL and NF-kappaB or AP-1(P>0.05).
CONCLUSION: Activation of both NF-kappaB and AP-1 may be required for ICH-1L/S-induced apoptosis in HCC, but not for Fas/FasL-mediated apoptosis. NF-kappaB and AP-1 may play important roles in the pathogenesis of human HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991283      PMCID: PMC4504886          DOI: 10.3748/wjg.v11.i25.3860

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.

Authors:  R E Bellas; M J FitzGerald; N Fausto; G E Sonenshein
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.

Authors:  N Sasaki; T Morisaki; K Hashizume; T Yao; M Tsuneyoshi; H Noshiro; K Nakamura; T Yamanaka; A Uchiyama; M Tanaka; M Katano
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

Review 3.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

4.  Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.

Authors:  M F Yuen; P C Wu; V C Lai; J Y Lau; C L Lai
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.

Authors:  K Fujikawa; K Shiraki; K Sugimoto; T Ito; T Yamanaka; K Takase; T Nakano
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

7.  Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?

Authors:  T Roskams; L Libbrecht; B Van Damme; V Desmet
Journal:  J Pathol       Date:  2000-06       Impact factor: 7.996

Review 8.  TP53 and liver carcinogenesis.

Authors:  Frank Staib; S Perwez Hussain; Lorne J Hofseth; Xin W Wang; Curtis C Harris
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

9.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

10.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Authors:  W Wang; J L Abbruzzese; D B Evans; L Larry; K R Cleary; P J Chiao
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  3 in total

1.  Significance of increased expression of decoy receptor 3 in chronic liver disease.

Authors:  S Kim; V Kotoula; P Hytiroglou; D Zardavas; L Zhang
Journal:  Dig Liver Dis       Date:  2009-02-04       Impact factor: 4.088

2.  TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.

Authors:  Adrien Daigeler; Christina Brenzel; Daniel Bulut; Anne Geisler; Christoph Hilgert; Marcus Lehnhardt; Hans U Steinau; Annegret Flier; Lars Steinstraesser; Ludger Klein-Hitpass; Ulrich Mittelkötter; Waldemar Uhl; Ansgar M Chromik
Journal:  J Exp Clin Cancer Res       Date:  2008-12-12

3.  Brazilein Suppresses Inflammation through Inactivation of IRAK4-NF-κB Pathway in LPS-Induced Raw264.7 Macrophage Cells.

Authors:  Kui-Jin Kim; Kye-Yoon Yoon; Hyung-Sun Yoon; Sei-Ryang Oh; Boo-Yong Lee
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.